Previous close | 13.30 |
Open | 13.30 |
Bid | 9.50 |
Ask | 14.40 |
Strike | 500.00 |
Expiry date | 2025-01-17 |
Day's range | 13.30 - 13.30 |
Contract range | N/A |
Volume | |
Open interest | 160 |
June 4, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that members of management will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on Tuesday, June 11, 2024 at 2:40 PM ET in Miami, FL. A live webcast of the fireside chat may be accessed on the Investors section of the argenx website at argenx.com/inv
Immunovant stock slumped Thursday — reversing a day-earlier jump — after pivoting its focus to what one analyst called "a backup compound."
Biohaven stock tumbled Wednesday after the company's experimental protein-degrading drug lagged investor expectations.